Virion Biotherapeutics
Z├╝rich
About Virion Biotherapeutics
Virion’s mission is a developer of biological antivirals creates to offer improved therapeutics for respiratory viral infections. The company's antivirals focus on prevention and treatment of influenza and respiratory syncytial virus (RSV), enabling doctors to get a broad-spectrum therapy for respiratory viral infections, potentially simplifying and accelerating treatment by removing the need for differential diagnosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $21.2M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2018)
- Website: virionbiotx.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/virion-biotherapeutics-69174 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.